author-photo

Joachim Yahalom

Memorial Sloan Kettering Cancer Center

429

Papers

20207

Citations

Citation Trend

Filter By

Papers (298) Sort By

Journal Conference Others

Novel Agents May be Preferable to Chemotherapy for Large B-Cell Lymphoma Progressing after CD19-CAR-T: A Multicenter Observational Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief Report.

2021 Journal of Cancer Education
Show All
- Source
- Cite
- Save
Citations (0)
Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patients.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Five-Year Experience Using Bridging Radiotherapy Prior to Chimeric Antigen Receptor (CAR) T-Cell Therapies for B-Cell Malignancies at Memorial Sloan Kettering Cancer Center

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
The presence of a bulky mediastinal mass of 7 cm or greater in diameter confers an adverse prognosis to patients with advanced Hodgkin lymphoma in case of negative interim PET/CT.

2021 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)
Excellent Response to Very Low Dose Radiation (4Gy) For Indolent B-cell Lymphomas: Is 4Gy Suitable for Curable Patients?

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Lesion Characteristics and Patterns of Failure in Diffuse Large B Cell Lymphoma Patients Treated with Bridging Radiotherapy Prior to Chimeric Antigen Receptor T Cell Therapy

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
Clinical Outcomes and CNS Relapse Risk in Patients with Primary Cutaneous DLBCL, Leg Type Treated in the Rituximab Era: Long-Term Follow-up of a Single-Center Experience

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Modern Radiotherapy for Extranodal Nasal-type NK/T-cell Lymphoma: Risk-adapted Therapy, Target Volume and Dose Guidelines from the International Lymphoma Radiation Oncology Group.

2021 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (4)